Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 27

Get the latest international news and world events from around the world.

Log in for authorized contributors

Brain mechanism behind ‘flashes of intuition’

Despite decades of research, the mechanisms behind fast flashes of insight that change how a person perceives their world, termed “one-shot learning,” have remained unknown. A mysterious type of one-shot learning is perceptual learning, in which seeing something once dramatically alters our ability to recognize it again.

Now a new study, the researchers address the moments when we first recognize a blurry object, a primal ability that enabled our ancestors to avoid threats.

Published in Nature Communications, the new work pinpoints for the first time the brain region called the high-level visual cortex (HLVC) as the place where “priors” — images seen in the past and stored — are accessed to enable one-shot perceptual learning.

“Our work revealed, not just where priors are stored, but also the brain computations involved,” said co-senior study author.

Importantly, past studies had shown that patients with schizophrenia and Parkinson’s disease have abnormal one-shot learning, such that previously stored priors overwhelm what a person is presently looking at to generate hallucinations.

“This study yielded a directly testable theory on how priors act up during hallucinations, and we are now investigating the related brain mechanisms in patients with neurological disorders to reveal what goes wrong,” added the author.

The research team is also looking into likely connections between the brain mechanisms behind visual perception and the better-known type of “aha moment” when we comprehend a new idea. ScienceMission sciencenewshighlights.

Continue reading “Brain mechanism behind ‘flashes of intuition’” | >

Discussing the implication of DNA methylation in human diseases

DNA methylation plays a critical role in gene expression regulation and has emerged as a robust biomarker of biological age. This modification will become heavier or site drift along with aging. Recently, it is termed epigenetic clocks—such as Horvath, Hannum, PhenoAge, and GrimAge—leverage specific methylation patterns to accurately predict age-related decline, disease risk, and mortality. These tools are now widely applied across diverse tissues, populations, and disease contexts. Beyond age-related loss of methylation control, accelerated DNA methylation age has been linked to environmental exposures, lifestyle factors, and chronic diseases, further reinforcing its value as a dynamic and clinically relevant marker of biological aging. DNA methylation is reshaping our understanding of aging and disease risk, with promising implications for preventive medicine and interventions aimed at promoting healthy longevity. However, it must be admitted that some challenges remain, including limited generalizability across populations, an unclear mechanism, and inconsistent longitudinal performance. In this review, we examine the biological foundations of DNA methylation, major advances in epigenetic clock development, and their expanding applications in aging research, disease prediction and health monitoring.

Aging is a complex, multifactorial process that affects nearly all biological systems. While chronological age simply measures the passage of time from birth, biological age reflects the functional state and health of an individual’s tissues and organs (Kiselev et al., 2025). This distinction is critical, as individuals of the same chronological age often exhibit markedly different biological conditions, disease risks, and mortality trajectories (Dugue et al., 2018). Therefore, biological age potentially serves as a more meaningful measure of aging-related decline and is increasingly used to assess overall health status, predict disease onset, and evaluate the effectiveness of interventions aimed at promoting healthy longevity (Dugue et al., 2018; Petkovich et al., 2017).

Among various biomarkers proposed to estimate biological age, epigenetic modifications—particularly DNA methylation—have emerged as one of the most reliable and informative (Dugue et al., 2018). In epigenetics, DNA methylation involves the addition of a methyl group to the 5′ position of cytosine residues, typically at CpG dinucleotides, which can regulate gene expression without altering the underlying DNA sequence. Moreover, DNA methylation can be accurately measured by sequencing at methylated sites with bisulfate treatment (Zhang et al., 2012). Age-related changes in DNA methylation pattern are not random; they occur at specific genomic locations. These methylated sites are picked and constitute come patterns, by which scientists can construct “epigenetic clocks” to precisely estimate a person’s biological age based on their DNA modification. As people grow older, their methylation profiles shift in predictable ways (Kiselev et al., 2025; Horvath, 2013; Horvath and Raj, 2018).

Early signs of Parkinson’s can be identified in the blood

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage has occurred. The biological processes leave measurable traces in the blood, but only for a limited period.

The discovery thus reveals a window of opportunity that could be crucial for future treatment, but also for early diagnosis via blood tests, which could begin to be tested in health care within five years.

Parkinson’s is an endemic disease with over 10 million people affected globally. As the world’s population grows older, this number is expected to more than double by 2050. At present, there is neither an effective cure nor an established screening method for detecting this chronic neurological disorder at an early stage before it has caused significant damage to the brain.

A possible ice-cold Earth discovered in the archives of the retired Kepler Space Telescope

Scientists continue to mine data gathered by NASA’s Kepler Space Telescope, retired in 2018, and continue to turn up surprises. A new paper reveals the latest: a possible rocky planet slightly larger than Earth, orbiting a sun-like star about 146 light-years away. The candidate planet, HD 137010b, might be remarkably similar to Earth, but it has one potentially big difference: It could be colder than perpetually frozen Mars.

A promising Earth-sized exoplanet emerges An international science team published a paper on the discovery, “A Cool Earth-sized Planet Candidate Transiting a Tenth Magnitude K-dwarf From K2,” in The Astrophysical Journal Letters on Jan. 27, 2026. The team was led by astrophysics Ph.D. student Alexander Venner of the University of Southern Queensland, Toowoomba, Australia, now a postdoctoral researcher at the Max Planck Institute for Astronomy, Heidelberg, Germany.

The orbital period of the planet—listed as a “candidate” pending further confirmation—is likely to be similar to Earth’s, around one year. Planet HD 137,010 b also might fall just within the outer edge of its star’s “habitable zone,” the orbital distance that could allow liquid water to form on the planet’s surface under a suitable atmosphere.

Q-Day: Catastrophic For Businesses Ignoring Quantum-Resistant Encryption

#Quantum #CyberSecurity

Quantum computing is not merely a frontier of innovation; it is a countdown. Q-Day is the pivotal moment when scalable quantum computers undermine the cryptographic underpinnings of our digital realm. It is approaching more rapidly than many comprehend.

For corporations and governmental entities reliant on outdated encryption methods, Q-Day will not herald a smooth transition; it may signify a digital catastrophe.

Comprehending Q-Day: The Quantum Reckoning

Q-Day arrives when quantum machines using Shor’s algorithm can dismantle public-key encryption within minutes—a task that classical supercomputers would require billions of years to accomplish.

A large language model for complex cardiology care

In a randomized study involving 9 general cardiologists and 107 real-world patient cases, assistance from a specifically tailored large language model resulted in preferable responses on complex case management compared to physicians alone, as rated by specialist cardiologists using a multidimensional scoring rubric.

New clue to treating hypertension: Blocking a brain receptor may calm blood pressure signals

The human body is often described in parts—different limbs, systems, and organs—rather than something fully interconnected and whole. Yet many bodily processes interact in ways we may not always recognize. For example, researchers at the University of Missouri School of Medicine may have found a link between high blood pressure and an overactive nervous system.

The paper is published in the journal Cardiovascular Research.

High blood pressure, also called hypertension, is a common cardiovascular condition and a risk factor for multiple diseases and sudden health concerns like stroke or heart attack.

/* */